Skip to main content
Top
Published in: Archives of Virology 2/2009

01-02-2009 | Original Article

HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9

Authors: Kozaburo Hayashi, Laura C. Hooper, Barbara Detrick, John J. Hooks

Published in: Archives of Virology | Issue 2/2009

Login to get access

Abstract

Angiogenesis and inflammatory mediators are critical pathogenic factors in herpetic stromal keratitis (HSK). Since disease progresses without infectious virus, HSV-DNA and HSV-IgG complexes (HSV-IC) may contribute to HSK by triggering these factors. Production of VEGF and MMP-9 was studied in vitro using corneal epithelial cells (HCE), fibroblasts (HCRF) and macrophages (THP-1). VEGF was elevated in HCRF and THP-1 following treatment with HSV-DNA and HSV-IC. MMP-9 was elevated in THP-1 but not in corneal cells. When anti-HSV-IgG(Fab′)2 complexes stimulated THP-1, MMP-9 was reduced to control levels. Pretreatment of THP-1 with anti-TLR-2 and -3 inhibited MMP-9 production. Thus, HSV-IC may stimulate THP-1 through the Fc receptor and TLRs. Proinflammatory cytokines (IL-1b, IL-6, and TNF-α) increased VEGF and MMP-9 in corneal cells and macrophages. These studies indicate that the continued presence of HSV-DNA and HSV-IC contribute to angiogenesis and inflammation in HSK. Thus, cytokines and TLRs may be potential targets for intervention.
Literature
1.
go back to reference Akira S, Takeda K (2004) Toll like receptor signaling. Nat Rev Immunol 4:499–511PubMed Akira S, Takeda K (2004) Toll like receptor signaling. Nat Rev Immunol 4:499–511PubMed
2.
go back to reference Akira S, Uematsu S et al (2006) Pathogen recognition and innate immunity. Cell 124:783–880PubMed Akira S, Uematsu S et al (2006) Pathogen recognition and innate immunity. Cell 124:783–880PubMed
3.
go back to reference Banerjee K, Biswas PS et al (2005) Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukocyte Biol 77:24–32PubMed Banerjee K, Biswas PS et al (2005) Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukocyte Biol 77:24–32PubMed
4.
go back to reference Biswas PS, Banerjee K et al (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82:46–54PubMed Biswas PS, Banerjee K et al (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82:46–54PubMed
5.
go back to reference Biswas PS, Rouse BT (2005) Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 7:799–810PubMed Biswas PS, Rouse BT (2005) Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 7:799–810PubMed
6.
go back to reference Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014–1018PubMed Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014–1018PubMed
7.
go back to reference Blander JM (2007) Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol 28:19–25PubMed Blander JM (2007) Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol 28:19–25PubMed
8.
go back to reference Cox D, Tseng CC et al (1997) A requirement for phosphoinositol 3-kinase in pseodopod extension. J Biol Chem 274:1240–1247 Cox D, Tseng CC et al (1997) A requirement for phosphoinositol 3-kinase in pseodopod extension. J Biol Chem 274:1240–1247
9.
go back to reference Hayashi K, Hooper LC et al (2006) Herpes simplex virus 1(HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 87:2161–2169PubMed Hayashi K, Hooper LC et al (2006) Herpes simplex virus 1(HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 87:2161–2169PubMed
10.
go back to reference Kwong AD, Kruper JA et al (1988) Herpes simplex virus virion host shut off function. J Virol 62:912–921PubMed Kwong AD, Kruper JA et al (1988) Herpes simplex virus virion host shut off function. J Virol 62:912–921PubMed
11.
go back to reference Lee S, Zheng M et al (2002) Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110:1105–1111PubMed Lee S, Zheng M et al (2002) Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110:1105–1111PubMed
12.
go back to reference Li X, Tupper JC et al (2003) Phosphoinositide-3 kinase mediate Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 71:4414–4420PubMed Li X, Tupper JC et al (2003) Phosphoinositide-3 kinase mediate Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 71:4414–4420PubMed
13.
go back to reference Liesengang TS (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20:1–13 Liesengang TS (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20:1–13
14.
go back to reference Matsumoto M, Kikkawa S et al (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364–1369PubMed Matsumoto M, Kikkawa S et al (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364–1369PubMed
15.
go back to reference Meyers-Elliott RH, Pettit TH et al (1980) Viral antigens in the immune ring of herpes simplex stromal keratits. Arch Ophthalmol 98:897–904PubMed Meyers-Elliott RH, Pettit TH et al (1980) Viral antigens in the immune ring of herpes simplex stromal keratits. Arch Ophthalmol 98:897–904PubMed
16.
go back to reference Opremcak EM, Rice BA et al (1990) Histology and immunohistology of Ig-h-1-restricted herpes simplex keratitisin Balb/c congenic mice. Invest Ophthalmol Vis Sci 31:305–312PubMed Opremcak EM, Rice BA et al (1990) Histology and immunohistology of Ig-h-1-restricted herpes simplex keratitisin Balb/c congenic mice. Invest Ophthalmol Vis Sci 31:305–312PubMed
17.
go back to reference Sciortino M-T, Suzuki M et al (2001) RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol 75:8105–8116PubMed Sciortino M-T, Suzuki M et al (2001) RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol 75:8105–8116PubMed
18.
go back to reference Sarkar SN, Peters KL et al (2004) Novel roles of TLR3 tyrosine phosphorylation and PI Kinase in double strand RNA signaling. Nat Struct Mol Biol 11:1060–1067PubMed Sarkar SN, Peters KL et al (2004) Novel roles of TLR3 tyrosine phosphorylation and PI Kinase in double strand RNA signaling. Nat Struct Mol Biol 11:1060–1067PubMed
19.
go back to reference Shimomura Y, Deai T et al (2007) Corneal buttons obtained from HSK patients harbor high copy number of the HSV genome. Cornea 26:190–193PubMed Shimomura Y, Deai T et al (2007) Corneal buttons obtained from HSK patients harbor high copy number of the HSV genome. Cornea 26:190–193PubMed
20.
go back to reference Staats HF, Lausch RN (1993) Cytokine expression in vivo during murine herpetic stromal keratits. Effect of protective antibody therapy. J Immunol 151:277–283PubMed Staats HF, Lausch RN (1993) Cytokine expression in vivo during murine herpetic stromal keratits. Effect of protective antibody therapy. J Immunol 151:277–283PubMed
21.
go back to reference Toker A, Cantley LC (1997) Signaling through the lipid products of phosphoinositide-3-OH-kinase. Nature 387:673–676PubMed Toker A, Cantley LC (1997) Signaling through the lipid products of phosphoinositide-3-OH-kinase. Nature 387:673–676PubMed
22.
go back to reference Tsuchiya S, Kobayashi Y et al (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42:1530–1536PubMed Tsuchiya S, Kobayashi Y et al (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42:1530–1536PubMed
23.
go back to reference Ueta M, Hamuro J et al (2005) Triggering of TLR3 by poly I:C in human corneal epithelial cells to induce inflammatory cytopkines. Biochem Biophys Res Commun 331:285–294PubMed Ueta M, Hamuro J et al (2005) Triggering of TLR3 by poly I:C in human corneal epithelial cells to induce inflammatory cytopkines. Biochem Biophys Res Commun 331:285–294PubMed
24.
go back to reference Underhill DM, Gantner B (2004) Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect 6:1368–1373PubMed Underhill DM, Gantner B (2004) Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect 6:1368–1373PubMed
25.
go back to reference Underhill DM, Ozinsky A et al (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811–815PubMed Underhill DM, Ozinsky A et al (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811–815PubMed
26.
go back to reference Viahos CJ, Matter WF et al (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8 phenyl-4H-I-benzopyran-4-one (LY294002). J Boiol Chem 269:5241–5248 Viahos CJ, Matter WF et al (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8 phenyl-4H-I-benzopyran-4-one (LY294002). J Boiol Chem 269:5241–5248
27.
go back to reference Yang Y-N, Bauer D et al (2003) Matrix metalloproteases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res 77:227–237PubMed Yang Y-N, Bauer D et al (2003) Matrix metalloproteases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res 77:227–237PubMed
28.
go back to reference Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocutes in response to microbes, their products, and cytokines. J Immunol 168:554–561PubMed Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocutes in response to microbes, their products, and cytokines. J Immunol 168:554–561PubMed
29.
go back to reference Zheng M, Deshpande S et al (2001) Contribution of vascular endothelial growth factor in the neovacularization process during the pathogenesisof herpetic stromal keratitis. J Virol 75:9828–9835PubMed Zheng M, Deshpande S et al (2001) Contribution of vascular endothelial growth factor in the neovacularization process during the pathogenesisof herpetic stromal keratitis. J Virol 75:9828–9835PubMed
30.
go back to reference Zheng M, Schwarz MA et al (2001) Control of stromal keratits by inhibition of neovascularization. Am J Pathol 159:1021–1029PubMed Zheng M, Schwarz MA et al (2001) Control of stromal keratits by inhibition of neovascularization. Am J Pathol 159:1021–1029PubMed
Metadata
Title
HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9
Authors
Kozaburo Hayashi
Laura C. Hooper
Barbara Detrick
John J. Hooks
Publication date
01-02-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 2/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-008-0303-7

Other articles of this Issue 2/2009

Archives of Virology 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.